Highlights from CROI 2014 on Experimental HIV Drugs
Highlights from CROI 2014 on Experimental HIV Drugs
Eva Poveda 1, José D. Pedreira 1
1 NULL
*Correspondence: Eva Poveda, Email not available
Abstract
Despite the extensive therapeutic arsenal currently available to treat HIV infection, new agents allowing long-term safety and tolerability, with novel mechanism of action and more convenient administration, would be desirable to fight this chronic infection. In this regard, news on this topic has been highlighted at the last CROI held in Boston at the beginning of March, 2014.
